CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net income (loss)	$ 31,819	$ (92,995)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Stock-based compensation	42,446	97,768
Depreciation and amortization	1,125	614
Non-cash operating lease expense	696	522
Warrants contra revenue	374	110
Accretion of discounts on marketable securities	(2,542)	(568)
Other, net	(1,025)	430
Changes in operating assets and liabilities:
Accounts receivable, net	(30,968)	(8,422)
Inventory	(6,787)	(5,900)
Prepaid expenses and other assets	(14,495)	(2,666)
Accounts payable	2,226	4,973
Accrued expenses and other liabilities	(11,676)	10,224
Operating lease liability	(689)	(438)
Net cash provided by operating activities	10,504	3,652
Cash flows from investing activities
Purchases of property and equipment	(4,539)	(3,424)
Purchases of marketable securities	(190,821)	(23,308)
Sales and maturities of marketable securities	191,420	22,481
Net cash used in investing activities	(3,940)	(4,251)
Cash flows from financing activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	0	672,198
Payment of deferred offering costs	0	(1,756)
Tax withholding related to net share settlements of restricted stock units	0	(20,111)
Proceeds from exercises of stock options, net of repurchases	386	1,247
Net cash provided by financing activities	386	651,578
Net increase in cash, cash equivalents, and restricted cash	6,950	650,979
Cash, cash equivalents, and restricted cash
Beginning of the period	80,044	45,098
End of the period	86,994	696,077
Supplemental disclosures of cash flow information:
Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering	0	255,127
Deferred offering costs included in accounts payable and accrued expenses	$ 0	$ 3,045